{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:56:21Z","timestamp":1789577781097,"version":"build-2803163510"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>A polymorphic variant in the ataxia telangiectasia-mutated (<jats:italic toggle=\"yes\">ATM<\/jats:italic>) gene, rs56009889, was recently associated with an increased risk of lung cancer. We studied the role of this variant in the etiology of other cancers. Data from three population-based case\u2013control studies of colon, breast, and lung cancer were used. Participants in these studies (4517 cases, 3383 controls) underwent a genome-wide association study using 500K Illumina OncoArray. The frequency of the AG\/AA genotypes differed between Ashkenazi (4.6%) and Sephardi (0.2%) Jews (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001). AG\/AA frequency was significantly higher in Ashkenazi lung cancer (11.9%) than in controls (2.8%) [adjusted odds ratio (OR)\u2005=\u20055.4]. Females had a higher risk than males (OR\u2005=\u200512.8 versus 3.5). The adjusted OR for colorectal cancer was 1.40 [95% confidence interval (CI)\u2005=\u20051.01\u20132.0, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.045] and for breast cancer was 1.43 (95% CI\u2005=\u20051.01\u20132.04, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.046). Never-smokers variant carriers were at higher risk of lung and colon, but not breast, cancer. Cases with the AG\/AA genotype had lower mean age at diagnosis, but this difference was significant only for breast cancer (\u22123.2 years, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.007). No associations were observed with overall survival. Among the breast cancer subjects, the OR for having triple-negative tumors was 0.45 for AG\/AA versus GG genotype (95% CI\u2005=\u20050.2\u20130.9, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.02). We confirm the strong association between <jats:italic toggle=\"yes\">ATM<\/jats:italic> rs56009889 and lung cancer risk in Ashkenazi Jews and report a mild association with the risk of breast cancer and colorectal cancer.<\/jats:p>","DOI":"10.1097\/cej.0000000000000906","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T12:05:26Z","timestamp":1723809926000},"page":"124-129","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Ataxia telangiectasia-mutated rs56009889 and risk of common cancers"],"prefix":"10.1097","volume":"34","author":[{"given":"Ofra","family":"Barnet-Griness","sequence":"first","affiliation":[{"name":"Department of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Gruber","sequence":"additional","affiliation":[{"name":"Precision Medicine Program, City of Hope, Duarte, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Lipkin","sequence":"additional","affiliation":[{"name":"Program in Mendelian Genetics, Weill-Cornell Medicine, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Shulman","sequence":"additional","affiliation":[{"name":"Haifa and Western Galilee District Oncology Service, Clalit Health Services"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Haddad","sequence":"additional","affiliation":[{"name":"Department of Surgery B"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Galili","sequence":"additional","affiliation":[{"name":"Chest Surgery Unit, Carmel Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Rennert","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel"},{"name":"Faculty of Medicine, Technion-Israel Institute of Technology"},{"name":"Association for Promotion of Research in Precision Medicine (APRPM) (A.R.), Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"key":"R2-20250130","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.30498","article-title":"A study of over 35\u2005000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.","volume":"123","author":"Buys","year":"2017","journal-title":"Cancer"},{"key":"R3-20250130","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1038\/onc.2013.275","article-title":"ATM signaling and cancer.","volume":"33","author":"Cremona","year":"2014","journal-title":"Oncogene"},{"key":"R4-20250130","doi-asserted-by":"crossref","first-page":"e0130393","DOI":"10.1371\/journal.pone.0130393","article-title":"Prevalence of germline mutations in genes engaged in DNA damage repair by homologous recombination in patients with triple-negative and hereditary non-triple-negative breast cancers.","volume":"10","author":"Domagala","year":"2015","journal-title":"PLoS One"},{"key":"R5-20250130","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.jtho.2020.08.017","article-title":"Inherited rare, deleterious variants in ATM increase lung adenocarcinoma risk.","volume":"15","author":"Esai Selvan","year":"2020","journal-title":"J Thorac Oncol"},{"key":"R6-20250130","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1093\/hmg\/5.12.2033","article-title":"Ataxia-telangiectasia: founder effect among North African Jews.","volume":"5","author":"Gilad","year":"1996","journal-title":"Hum Mol Genet"},{"key":"R7-20250130","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/bcr2919","article-title":"Rare variants in the ATM gene and risk of breast cancer.","volume":"13","author":"Goldgar","year":"2011","journal-title":"Breast Cancer Res"},{"key":"R8-20250130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.gde.2010.02.009","article-title":"Discovering moderate-risk breast cancer susceptibility genes.","volume":"20","author":"Hollestelle","year":"2010","journal-title":"Curr Opin Genet Dev"},{"key":"R9-20250130","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1096\/fj.11-185546","article-title":"Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways.","volume":"25","author":"Keimling","year":"2011","journal-title":"FASEB J"},{"key":"R10-20250130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/genes11010108","article-title":"ATM serine\/threonine kinase and its role in pancreatic risk.","volume":"11","author":"Nanda","year":"2020","journal-title":"Genes (Basel)"},{"key":"R11-20250130","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/bjc.2011.266","article-title":"Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours.","volume":"105","author":"Reiman","year":"2011","journal-title":"Br J Cancer"},{"key":"R12-20250130","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ng1837","article-title":"ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.","volume":"38","author":"Renwick","year":"2006","journal-title":"Nat Genet"},{"key":"R13-20250130","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","article-title":"A single ataxia telangiectasia gene with a product similar to PI-3 kinase.","volume":"268","author":"Savitsky","year":"1995","journal-title":"Science"},{"key":"R14-20250130","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature11282","article-title":"Recurrent R-spondin fusions in colon cancer.","volume":"488","author":"Seshagiri","year":"2012","journal-title":"Nature"},{"key":"R15-20250130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrc1011","article-title":"ATM and related protein kinases: safeguarding genome integrity.","volume":"3","author":"Shiloh","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"R16-20250130","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/jmedgenet-2016-103839","article-title":"PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.","volume":"53","author":"Southey","year":"2016","journal-title":"J Med Genet"},{"key":"R17-20250130","doi-asserted-by":"crossref","first-page":"770","DOI":"10.7326\/0003-4819-133-10-200011210-00009","article-title":"Mortality rates among carriers of ataxia-telangiectasia mutant alleles.","volume":"133","author":"Su","year":"2000","journal-title":"Ann Intern Med"},{"key":"R18-20250130","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM198705213162101","article-title":"Breast and other cancers in families with ataxia-telangiectasia.","volume":"316","author":"Swift","year":"1987","journal-title":"N Engl J Med"},{"key":"R19-20250130","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1056\/NEJM199112263252602","article-title":"Incidence of cancer in 161 families affected by ataxia-telangiectasia.","volume":"325","author":"Swift","year":"1991","journal-title":"N Engl J Med"},{"key":"R20-20250130","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jnci\/dji141","article-title":"Cancer risks and mortality in heterozygous ATM mutation carriers.","volume":"97","author":"Thompson","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R21-20250130","doi-asserted-by":"crossref","first-page":"8371","DOI":"10.1038\/s41598-017-07737-0","article-title":"Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies.","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"R22-20250130","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1158\/1055-9965.EPI-19-1085","article-title":"Association analysis of driver gene-related genetic variants identified novel lung cancer susceptibility loci with 20\u2005871 lung cancer cases and 15\u2005971 controls.","volume":"29","author":"Wang","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R23-20250130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/1753465817725716","article-title":"The role of the ataxia telangiectasia mutated gene in lung cancer: recent advances in research.","volume":"11","author":"Xu","year":"2017","journal-title":"Ther Adv Respir Dis"},{"key":"R24-20250130","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s11596-018-1938-6","article-title":"GLTSCR1, ATM, PPP1R13L and CD3EAP genetic variants and lung cancer risk in a Chinese population.","volume":"38","author":"Yin","year":"2018","journal-title":"Curr Med Sci"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T11:01:26Z","timestamp":1738234886000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000906","relation":{},"ISSN":["0959-8278","1473-5709"],"issn-type":[{"value":"0959-8278","type":"print"},{"value":"1473-5709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,16]]}}}